Programmed death-1 - Globe Thesis

Keyword [Programmed death-1] Result: 81 - 100 \| Page: 5 of 6
81.	Correlation Between The Expression Of PD-1/PD-L1 On NK Cells And HBV Infection
82.	Expression Of The Human PD-1 Extracellular Domain And Its Nanobody Screening
83.	Expression And Clinical Significance Of PD-1/PD-L1 In Children With Acute Lymphoblastic Leukemia
84.	The Role And Evaluation Of Anlotinib And PD-1 Inhibitors In Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Based On Interventional Therapy
85.	Expression Of TIM-3、PD-1 And EGFR In Non-small Cell Lung Cancer And Their Relationship With Clinical Characteristics And Prognosis
86.	Clinical Trial Of Programmed Death-1 Inhibitors Combined With Endostar And Cisplatin-based Chemotherapy In The First-line Treatment Of Advanced Squamous Cell Lung Cancer
87.	Clinical Characteristics And Related Analysis Of EGFR、ALK、ROS1 And PD-1/PD-L1 In Non-small Cell Lung Cancer
88.	Clinical Analysis Of PD-1 Receptor Inhibitor Combined With P-Gemox-Dex Regimen In The Primary Treatment Of Phase Ⅲ/Ⅳ Extranodal Natural Killer/T Cell Lymphoma
89.	Systematic Review Of The Efficacy And Safety Of Immunotherapy Combined With Chemotherapy In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
90.	TGF-β1 Induces Immune Escape By Enhancing PD-1 And CTLA-4 Expression On T Lymphocytes In Hepatocellular Carcinoma
91.	Correlation Between SPD-1 In Peripheral Blood Of Patients With Hepatocellular Carcinoma And Detection Of PD-1 In Hepatocellular Carcinoma Specimens And Its Relationship With Prognosis
92.	Construction For Prognostic Assessment Of Triple-negative Breast Cancer,Expressions And Clinical Significance Of Immune Checkpoint-related Proteins
93.	Study On The Main Active Ingredients Of Platycodon Grandiflorum Trigger Anti-tumor Mechanism Through Immune Regulation
94.	Identification And Characterization Of Small Molecule Inhibitors Against PD-L1
95.	Prognostic Value Of Peripheral Blood Biomarkers LIPI Or NLR For Survival Outcomes In Patients With Solid Tumors Receiving PD-1 Inhibitors
96.	Peripheral Clonal Deletion Induces Immune Tolerance By Targeting Programmed Death-1
97.	Study On The Gene Polymorphism And Immune Regulation In Patients With PD-1 Of Han,Kazak Atrial Fibrillation In Xinjiang
98.	Suppression Of HBV Gene Expression Through Base Editing And Restoration Of HBV-specific T Cell Function By PD-L1 Antibody
99.	Expression Levels Of Plasma PD-1Related Cytokines In Patients With Different HIV-1 Infected Progression
100.	Efficacy And Toxicity Analysis Of Immunotherapy For EGFR-positive Non-small Cell Lung Cancer Patients After Resistance To Targeted Drugs
<<First <Prev Next> Last>> Jump to